Search results
Found 30150 matches for
Vascular loss shown to be the primary hallmark of aging
4 February 2021
New Research from the Kusumbe group at the Kennedy Institute of Rheumatology identifies vascular attrition, marked by pericyte to fibroblast differentiation, as a primary hallmark of aging and highlights organ-specific vascular changes with age.
Understanding the first wave of COVID-19 and implications for tackling the ongoing pandemic: evidence from 5.5 million people from Catalonia, Spain
3 February 2021
Health outcomes during the first wave of COVID-19 in Catalonia, Spain, have been described in detail in a study published by Nature Communications.
New Capture the Fracture policy guidance highlights global need for post-fracture care programs
2 February 2021
‘Capture the Fracture® (CTF) Partnership – Guidance for Policy Shaping’ sets out a step-by-step approach to building secondary fracture prevention policy which can improve patient outcomes, save healthcare costs, and save lives.
Immunology preprint reviews launched in Nature Reviews Immunology
15 January 2021
The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.
A more tailored approach to treating psoriatic arthritis
8 January 2021
Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.
Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia
7 January 2021
The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.
WHiTE Four trial results!
5 January 2021
The WHiTE Four trial has now published its results in The Bone & Joint journal.
Professor Eleanor Stride recognised in New Year’s Honours list 2021
4 January 2021
Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering
Drug may boost vaccine responses in older adults
18 December 2020
A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults
FUTURE GB Trial opens to recruitment!
18 December 2020
The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!
Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research
18 December 2020
In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.
Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease
18 December 2020
Oxford University has today been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.
Plastic surgeons recommend a review of cancer excision guidelines after finding variations in effectiveness
15 December 2020
A systematic review finds Incomplete excision rates for basal cell carcinoma range from 4.7% to 20.4% against recommended guidelines of 5%.
3D imaging reveals the role of blood vessels in hormone production
11 December 2020
New research from the Kusumbe Group at the Kennedy Institute has shown a direct correlation between age-related decline in capillary and artery numbers and hormone production in the endocrine system.
£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships
10 December 2020
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
ARCADIAN trial opens to recruitment!
7 December 2020
The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!
NDORMS researcher receives an MRC Career Development Award
4 December 2020
Adam Cribbs has been awarded a prestigious MRC Career Development Award to further his research to identify therapeutic targets for multiple myeloma.
Researchers call for an urgent return to skin cancer surgery
27 November 2020
In a research letter to the British Journal of Surgery (BJS) a team of plastic surgeons reveal the effect of the COVID-19 pandemic on skin cancer surgery in the UK.
New breakthrough in the treatment of rheumatoid arthritis
25 November 2020
People with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
NDORMS researchers make Highly Cited Researchers list
19 November 2020
Professor Gary Collins, Professor Cyrus Cooper, Professor Fiona Powrie and the late Professor Doug Altman have been named on the annual Highly Cited Researchers™️ 2020 list from Clarivate.